Bio-XCell latest from GlycosBio and Metabolic Explorer
Last week, we toured the Bio-XCell industrial biotechnology park in the Nusajaya, Malaysia. The 160-acre site is currently home to four companies: pharmaceutical companies Stelis and Biocon, and bio-based material companies Metabolic Explorer (METEX) and GlycosBio. In our visit, we heard the late...
This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
Genetically modifies E. coli to convert gas feedstocks like CO2 and methane into higher‑value chemicals
Products of interest include 3‑hydroxypropionate (3‑HP) and its derivatives as well as novel polyhydroxyalkanoates (PHAs); developing other products with partners but would not disclose
Not part of subscription
Develops routes to high‑value‑added chemical products from renewable raw materials using a combination of fermentation and catalytic processes
Currently has four main bioproducts in its portfolio including acetoin, 2,3‑butanediol (2,3‑BDO), methyl ethyl ketone (MEK), and 1,3‑butadiene (1,3‑BD...
To read more,
Uses genetically modified Escherichia coli to produce bioisobutene at a premium in gaseous form; can be used unmodified as an additive in gaseous fuel bottles or converted into isooctane, isododecane, butyl rubber, polyisobutene, methacrylic acid, or ethyl tertiary butyl ether (ETBE)
To read more,